Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel antitumor protein kinase inhibitors in early development at Vertex

Sep. 19, 2003

AstraZeneca claims novel KDR inhibitors for cancer and other disorders

Sep. 19, 2003

Thymitaq studied in new phase I/II trial in combination with Taxotere

Sep. 19, 2003

SBIR grant supports development of melanoma peptide vaccine

Sep. 19, 2003

Clofarabine enters pivotal European trial for ALL

Sep. 19, 2003

Structurally novel vascular targeting agent discovered by Oxigene and Baylor U.

Sep. 18, 2003

New FAP-activated prodrugs of antitumor agents claimed by Boehringer Ingelheim

Sep. 18, 2003

Japan Tobacco discontinues JTE-522 development

Sep. 18, 2003

Limited activity described for exatecan mesilate as first-line monotherapy in NSCLC

Sep. 18, 2003

Odyssey and Dharmacon investigate effects of siRNA-induced gene silencing

Sep. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...